Ainos (AIMDW) Competitors

$0.08 +0.01 (+11.11%)

As of 12:48 PM Eastern

AIMDW vs. ALVOW, ARAV, ACABW, RNA, and BFRIW

Should you buy Ainos stock or one of its competitors? MarketBeat compares Ainos with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ainos include Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Avidity Biosciences (RNA), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Ainos compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
Ainos	$18.11K	N/A	N/A	N/A	N/A

In the previous week, Ainos had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Alvotech. Alvotech's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company	Overall Sentiment
Alvotech	Neutral
Ainos	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Ainos	N/A	N/A	N/A

Summary

Alvotech and Ainos tied by winning 1 of the 2 factors compared between the two stocks.

How does Ainos compare to Aravive?

Ainos (NASDAQ:AIMDW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$18.11K	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Ainos had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Aravive. Ainos' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company	Overall Sentiment
Ainos	Neutral
Aravive	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

Summary

Ainos and Aravive tied by winning 2 of the 4 factors compared between the two stocks.

How does Ainos compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Ainos (NASDAQ:AIMDW) are both pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
Ainos	$18.11K	N/A	N/A	N/A	N/A

In the previous week, Ainos had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Atlantic Coastal Acquisition Corp. II. Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
Ainos	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
Ainos	N/A	N/A	N/A

Summary

Ainos beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Ainos compare to Avidity Biosciences?

Avidity Biosciences (NASDAQ:RNA) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

In the previous week, Avidity Biosciences had 4 more articles in the media than Ainos. MarketBeat recorded 5 mentions for Avidity Biosciences and 1 mentions for Ainos. Avidity Biosciences' average media sentiment score of 0.80 beat Ainos' score of 0.00 indicating that Avidity Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avidity Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ainos	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Avidity Biosciences currently has a consensus target price of $69.42, suggesting a potential upside of 433.19%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, equities research analysts plainly believe Avidity Biosciences is more favorable than Ainos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avidity Biosciences	1 Sell rating(s)	11 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.37
Ainos	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Ainos has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Ainos' return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avidity Biosciences	-3,650.39%	-44.92%	-39.57%
Ainos	N/A	N/A	N/A

Ainos has lower revenue, but higher earnings than Avidity Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avidity Biosciences	$36.68M	6.07	-$322.30M	N/A	N/A
Ainos	$18.11K	N/A	N/A	N/A	N/A

Summary

Avidity Biosciences beats Ainos on 7 of the 10 factors compared between the two stocks.

How does Ainos compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
Ainos	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$41.71M	N/A	N/A	N/A	N/A
Ainos	$18.11K	N/A	N/A	N/A	N/A

In the previous week, Ainos had 1 more articles in the media than Biofrontera. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Biofrontera. Biofrontera's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company	Overall Sentiment
Biofrontera	Neutral
Ainos	Neutral

Summary

Biofrontera and Ainos tied by winning 1 of the 2 factors compared between the two stocks.

Get Ainos News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIMDW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AIMDW vs. The Competition

Export

Metric	Ainos	Medical Devices Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$2.07B	$6.29B	$12.14B
Dividend Yield	N/A	2.67%	2.80%	5.32%
P/E Ratio	N/A	13.89	20.64	25.12
Price / Sales	N/A	129.47	580.02	92.21
Price / Cash	N/A	15.99	27.48	37.30
Price / Book	N/A	4.42	9.75	6.62
Net Income	N/A	$144.75M	$3.55B	$335.39M
7 Day Performance	N/A	-1.80%	-1.59%	-1.72%
1 Month Performance	N/A	1.02%	-3.51%	-1.61%
1 Year Performance	N/A	7.28%	30.08%	27.79%

Ainos Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AIMDW Ainos	N/A	$0.08 +11.1%	N/A	-54.3%	$0.00	$18.11K	N/A	40	News Coverage Gap Up
ALVOW Alvotech	N/A	$0.20 -2.8%	N/A	-87.9%	$0.00	$586.32M	N/A	4
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15
RNA Avidity Biosciences	2.3215 of 5 stars	$13.07 +0.8%	$69.42 +431.1%	-57.3%	$0.00	$18.62M	N/A	190	Earnings Report Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AIMDW) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ainos (AIMDW) Competitors